Clinical Trial

The Effect of Symbiotic Beverage Consumption on Lipid Profile

Study acronym: SYMBIONIC
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated June 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate whether the synbiotic beverage "Daygurt" can improve lipid profiles, blood sugar levels, blood pressure, and body weight in individuals diagnosed with dyslipidemia. The main questions it aims to answer are: Does "Daygurt" significantly reduce total cholesterol and LDL levels compared to nutrition counseling alone? Does "Daygurt" increase HDL levels and reduce triglycerides more effectively than nutrition counseling? Does "Daygurt" lead to greater improvements in fasting blood sugar, blood pressure, and body weight compared to nutrition counseling? The intervention group (receiving "Daygurt" plus nutrition counseling) will be compared to the comparison group (receiving nutrition counseling without "Daygurt") to see if "Daygurt" provides additional benefits beyond standard dietary advice. Participants will be divided into 2 groups: Intervention group: Consume "Daygurt" daily for 8 weeks. Comparison group: Receive nutrition counseling sessions focused on managing dyslipidemia but will not consume "Daygurt." Both groups will undergo health parameter measurements before and after the intervention, including: Total cholesterol, LDL, HDL, and triglyceride levels. Fasting blood sugar. Blood pressure. Body mass index (BMI).
Trial Details
NCT Number NCT06893991
Lead Sponsor Politeknik Kesehatan Kemenkes Padang
Conditions Lipid Profile, Fasting Blood Sugar Above Normal, Body Mass Index
Enrollment 60 participants
Start Date 2025-02-27
Primary Completion 2025-06-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-25